BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6643332)

  • 1. Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study.
    Dyas A; Wise R; Pijck J; Hallynck T; Acar J; Adam D; Cadorniga R; Wenk M; Soep HH
    J Antimicrob Chemother; 1983 Oct; 12(4):371-6. PubMed ID: 6643332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
    Bauer LA; Blouin RA
    Eur J Clin Pharmacol; 1983; 24(5):639-42. PubMed ID: 6873143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin, tobramycin, amikacin, and netilmicin levels in tears following intravenous administration.
    Woo FL; Johnson AP; Insler MS; George WJ; LaCorte WS
    Arch Ophthalmol; 1985 Feb; 103(2):216-8. PubMed ID: 3977692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
    Federspil P; Schätzle W; Tiesler E
    J Infect Dis; 1976 Aug; 134 Suppl():S200-5. PubMed ID: 972282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacokinetics of amikacin and gentamicin in volunteers: a comparison of individual differences.
    Walker JM; Wise R; Mitchard M
    J Antimicrob Chemother; 1979 Jan; 5(1):95-9. PubMed ID: 762009
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal accumulation of amikacin, tobramycin and gentamycin in the rat.
    Nieminen L; Kasanen A; Kangas L; Sairio E; Anttila M
    Experientia; 1978 Oct; 34(10):1335-6. PubMed ID: 738411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microbiology and pharmacokinetics of gentamicin, sisomicin, netilmicin and amikacin].
    Naumann P; Rosin H
    Adv Clin Pharmacol; 1978; 15():23-34. PubMed ID: 676876
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
    Lode H; Grunert K; Kemmerich B; Koeppe P
    Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure.
    Blair DC; Duggan DO; Schroeder ET
    Antimicrob Agents Chemother; 1982 Sep; 22(3):376-9. PubMed ID: 7137981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the pharmacokinetics of amikacin and gentamicin.
    Wise R; Walker JM; Mitchard M
    J Antimicrob Chemother; 1981 Jul; 8 Suppl A():45-9. PubMed ID: 7263565
    [No Abstract]   [Full Text] [Related]  

  • 16. Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
    Block CS; Fabian B; Robinson RG
    S Afr Med J; 1978 Mar; 53(11):396-99. PubMed ID: 675374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.
    French MA; Cerra FB; Plaut ME; Schentag JJ
    Antimicrob Agents Chemother; 1981 Jan; 19(1):147-52. PubMed ID: 7247354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine concentrations of gentamicin, tobramycin, amikacin, and kanamycin after subcutaneous administration to healthy adult dogs.
    Ling GV; Conzelman GM; Franti CE; Ruby AL
    Am J Vet Res; 1981 Oct; 42(10):1792-4. PubMed ID: 7325444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nephrotoxicity and renal accumulation of amikacin, tobramycin and gentamycin in rats, rabbits and guinea pigs.
    Sairio E; Kasanen A; Kangas L; Nieminen AL; Nieminen L
    Exp Pathol (Jena); 1978; 15(6):370-5. PubMed ID: 744211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of lividomycin, amikacin and sisomicin in normal subjects and in uraemic patients.
    Leroy A; Humbert G; Oksenhendler G; Fillastre JP
    J Antimicrob Chemother; 1976 Dec; 2(4):373-81. PubMed ID: 1052072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.